StonvexLoading…
StonvexStonvexStonvexCore line items from LION's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 |
|---|---|---|---|
Revenue | $3.20B | $2.99B | $3.08B |
Operating Income | $124.60M | $139.70M | $139.60M |
Net Income | $-362.00M | $-1.10B | $-2.01B |
EPS (Diluted) | $-0.43 | $-0.42 | $0.00 |
Total Assets | $5.12B | $5.10B | Not available |
Total Liabilities | $6.04B | $6.13B | Not available |
Cash & Equivalents | $205.70M | $277.00M | $251.40M |
Free Cash Flow OCF − CapEx | $-120.30M | $479.00M | $339.60M |
Shares Outstanding | 284.60M | 253.40M | 253.40M |